REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Mar 22, 2024 8-K
10-K Mar 22, 2024 10-K
8-K Mar 12, 2024 8-K
SC 13G/A Feb 13, 2024
SCHEDULE 13G/A Feb 12, 2024
8-K Feb 8, 2024 8-K
424B3 Feb 2, 2024 PROSPECTUS
EFFECT Jan 31, 2024
8-K Jan 30, 2024 8-K
CORRESP Jan 30, 2024
S-1/A Jan 30, 2024 REGISTRATION STATEMENT
S-1/A Jan 29, 2024 REGISTRATION STATEMENT
CORRESP Jan 29, 2024
8-K Jan 23, 2024 8-K
8-K Jan 22, 2024 8-K
SC 13G Jan 3, 2024 REVB 13G 1.03.24
UPLOAD Jan 2, 2024
DEF 14A Dec 22, 2023 DEF 14A
S-1 Dec 22, 2023 REGISTRATION STATEMENT
PRE 14A Dec 12, 2023 PRE 14A
4 Dec 12, 2023 FORM 4 SUBMISSION
8-K Nov 13, 2023 8-K
10-Q Nov 9, 2023 10-Q
4 Oct 18, 2023 FORM 4 SUBMISSION
4 Oct 17, 2023 FORM 4 SUBMISSION
← Newer Page 7 of 16 · 387 filings Older →